Cargando…
Low expression of γ-glutamyl hydrolase mRNA in primary colorectal cancer with the CpG island methylator phenotype
The CpG island methylator phenotype (CIMP+) in colorectal cancer (CRC) is defined as concomitant and frequent hypermethylation of CpG islands within gene promoter regions. We previously demonstrated that CIMP+ was associated with elevated concentrations of folate intermediates in tumour tissues. In...
Autores principales: | Kawakami, K, Ooyama, A, Ruszkiewicz, A, Jin, M, Watanabe, G, Moore, J, Oka, T, Iacopetta, B, Minamoto, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391094/ https://www.ncbi.nlm.nih.gov/pubmed/18414409 http://dx.doi.org/10.1038/sj.bjc.6604346 |
Ejemplares similares
-
CpG-island methylation study of liver fluke-related cholangiocarcinoma
por: Sriraksa, R, et al.
Publicado: (2011) -
NT5E CpG island methylation is a favourable breast cancer biomarker
por: Lo Nigro, C, et al.
Publicado: (2012) -
No association of CpG island methylator phenotype and colorectal cancer survival: population-based study
por: Jia, Min, et al.
Publicado: (2016) -
Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location
por: Bae, J M, et al.
Publicado: (2013) -
γ-Glutamyl transferase and breast cancer risk
por: Fentiman, I S, et al.
Publicado: (2010)